Savara Inc — Investor Relations & Filings
Filings indexed
1,005
across all filing types
Latest filing
2026-04-24
Annual Report
Country
US
United States of America
Listing
US
SVRA
Savara Inc. is a clinical-stage biopharmaceutical company that develops therapies for rare respiratory diseases. The company's lead product candidate is molgramostim nebulizer solution, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). This candidate, which has the conditionally accepted trade name MOLBREEVI, is in Phase 3 development for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP), a rare lung disease. Savara has completed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration for MOLBREEVI for this indication.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Savara Inc (0001160308) (Filer) | 2026-04-24 | English | |
| 4 - Savara Inc (0001160308) (Issuer) | 2026-03-20 | English | |
| 4 - SAVARA INC (0001160308) (Filer) | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| SCHEDULE 13G/A Filing | 2026-02-05 | English | |
| 8-K Filing | 2026-01-27 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 36268004 | ARS - Savara Inc (0001160308) (Filer) | 2026-04-24 | English | ||
| 33002189 | 4 - Savara Inc (0001160308) (Issuer) | 2026-03-20 | English | ||
| 32888388 | 4 - SAVARA INC (0001160308) (Filer) | 2026-02-17 | English | ||
| 28250738 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 28250805 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 28250806 | 8-K Filing | 2026-01-27 | English | ||
| 28250840 | 8-K Filing | 2026-01-09 | English | ||
|
2025
8 filings
| |||||
| 11479302 | 4 | 2025-12-19 | English | ||
| 11479305 | Regulatory Filings 2025 | 2025-12-18 | English | ||
| 11479304 | 4 | 2025-12-16 | English | ||
| 11479306 | 4 | 2025-12-16 | English | ||
| 11479307 | 4 | 2025-12-16 | English | ||
| 11479308 | 4 | 2025-12-16 | English | ||
| 11479309 | 4 | 2025-12-16 | English | ||
| 11479310 | 4 | 2025-12-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Savara Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32709/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32709 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32709 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32709 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32709}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Savara Inc (id: 32709)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.